| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
glutathione S-transferase theta 1 | 0.393 | 0.923 | 1.5E-04 |
|
disease | 0.100 | None | 0.759 | 51 | 0 | 1996 | 2019 | ||||||||
|
erb-b2 receptor tyrosine kinase 2 | 0.328 | 0.923 | 6.0E-03 |
|
disease | 0.100 | None | 1.000 | 39 | 0 | 1991 | 2020 | ||||||||
|
androgen receptor | 0.351 | 0.846 | 0.99 |
|
disease | 0.100 | None | 1.000 | 38 | 0 | 2004 | 2020 | ||||||||
|
urothelial cancer associated 1 | 0.512 | 0.808 |
|
disease | 0.100 | None | 1.000 | 38 | 0 | 2006 | 2020 | |||||||||
|
hematopoietic prostaglandin D synthase | 0.388 | 0.923 | 1.8E-06 |
|
disease | 0.100 | None | 1.000 | 37 | 0 | 1995 | 2018 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma | 0.320 | 0.885 | 1.4E-06 |
|
disease | 0.100 | None | 1.000 | 34 | 0 | 2009 | 2020 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta | 0.322 | 0.885 | 1.00 |
|
disease | 0.100 | None | 1.000 | 33 | 0 | 2009 | 2020 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta | 0.319 | 0.885 | 1.00 |
|
disease | 0.100 | None | 1.000 | 33 | 0 | 2009 | 2020 | ||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
disease | 0.300 | None | 0.967 | 30 | 0 | 2001 | 2019 | ||||||||
|
H3 histone pseudogene 10 | 0.350 | 0.846 |
|
disease | 0.100 | None | 1.000 | 26 | 0 | 1995 | 2019 | |||||||||
|
microRNA 145 | 0.431 | 0.846 |
|
disease | 0.400 | None | 0.923 | 25 | 0 | 2010 | 2019 | |||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
disease | 0.100 | None | 1.000 | 23 | 0 | 1998 | 2019 | ||||||||
|
N-acetyltransferase 1 | 0.536 | 0.846 | 1.9E-14 |
|
disease | 0.400 | None | 0.760 | 23 | 0 | 1995 | 2017 | ||||||||
|
keratin 20 | 0.388 | 0.846 | 9.1E-11 |
|
disease | 0.100 | None | 1.000 | 21 | 0 | 1998 | 2019 | ||||||||
|
CD44 molecule (Indian blood group) | 0.363 | 0.962 | 2.4E-07 |
|
disease | 0.100 | None | 1.000 | 21 | 0 | 1994 | 2020 | ||||||||
|
hypoxia inducible factor 1 subunit alpha | 0.327 | 0.923 | 0.98 |
|
disease | 0.100 | None | 0.952 | 20 | 0 | 2001 | 2018 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
disease | 0.400 | None | 1.000 | 19 | 0 | 1990 | 2019 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
disease | 0.400 | None | 0.950 | 19 | 0 | 1991 | 2018 | ||||||||
|
signal transducer and activator of transcription 3 | 0.320 | 0.923 | 1.00 |
|
disease | 0.100 | None | 1.000 | 18 | 0 | 2008 | 2019 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
disease | 0.100 | None | 1.000 | 17 | 0 | 1997 | 2019 | ||||||||
|
TERT 5' regulatory region | 0.464 | 0.731 |
|
disease | 0.100 | None | 0.938 | 16 | 0 | 2013 | 2020 | |||||||||
|
TSC complex subunit 1 | 0.440 | 0.808 | 1.00 |
|
disease | 0.600 | None | 0.875 | 16 | 0 | 1999 | 2019 | ||||||||
|
uroplakin 2 | 0.691 | 0.346 | 3.0E-08 |
|
disease | 0.100 | None | 1.000 | 15 | 0 | 2002 | 2019 | ||||||||
|
solute carrier organic anion transporter family member 6A1 | 0.412 | 0.885 | 2.9E-11 |
|
disease | 0.100 | None | 1.000 | 14 | 0 | 1995 | 2017 | ||||||||
|
ELAV like RNA binding protein 3 | 0.705 | 0.385 | 0.77 |
|
disease | 0.100 | None | 0.929 | 14 | 0 | 2007 | 2020 |